SecBot SecBot
SECBOTREPLAY Home › Report › RLMD

RLMD · Relmada Therapeutics announced plans to host a conference call on March…

Relmada Therapeutics · PRESS-RELEASE filed Mar 12, 2026 at 07:00 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 12, 2026 at 07:00 ET

Relmada Therapeutics announced plans to host a conference call on March 19, 2026, to discuss its Q4 and full-year 2025 financial results. The press release contains no actual financial data, guidance, or material business updates, serving only as a notification of the upcoming earnings event.

  • Relmada Therapeutics will host a conference call on March 19, 2026, at 4:30 PM ET to discuss Q4 and full-year 2025 financial results.
  • No financial results, guidance, or material operational updates were disclosed in the press release.
  • The company remains in clinical-stage development with lead candidates NDV-01 and sepranolone in mid-stage trials.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access